Search Results

Filter
  • 1-10 of  49 results for ""Olgen S""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Periodical

Synthesis and Antiviral Activity of Oxaselenolane Nucleosides

  • Source: Journal of Medicinal Chemistry; October 19, 2000, Vol. 43 Issue: 21 p3906-3912, 7p

Record details

×
Academic Journal

Synthesis and Anticancer Activity of Novel Indole Derivatives as Dual EGFR/SRC Kinase Inhibitors.

  • Authors : Olgen S; Biruni University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, 34010, Zeytinburnu, Istanbul Turkey.; Biltekin Kaleli SN

  • Source: Current medicinal chemistry [Curr Med Chem] 2023 Jun 26. Date of Electronic Publication: 2023 Jun 26.Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 9440157 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Investigating the Activity of Indole-2-on Derivative Src Kinase Inhibitors Against Chronic Myeloid Leukemia Cells.

  • Authors : Cort-Donmez A; Department of Medical Biochemistry, Faculty of Medicine, Pamukkale University 20160, Denizli, Turkey.; Olgen S

Subjects: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/metabolism ; Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/pharmacology

  • Source: Anti-cancer agents in medicinal chemistry [Anticancer Agents Med Chem] 2023; Vol. 23 (1), pp. 113-122.Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 101265649 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A Prospective Overview of Drug Repurposing in Drug Discovery and Development.

  • Authors : Olgen S; Department of Pharmaceutical Chemistry Faculty of Pharmacy, Biruni University Istanbul, Turkey.

Subjects: Drug Development* ; Drug Discovery* ; Drug Repositioning*

  • Source: Current medicinal chemistry [Curr Med Chem] 2019; Vol. 26 (28), pp. 5338-5339.Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 9440157 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Drug Repurposing in the Development of Anticancer Agents.

  • Authors : Olgen S; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Biruni University, Istanbul, Turkey.; Kotra LP

Subjects: Drug Development* ; Drug Repositioning*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use

  • Source: Current medicinal chemistry [Curr Med Chem] 2019; Vol. 26 (28), pp. 5410-5427.Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 9440157 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

SAHAquines, Novel Hybrids Based on SAHA and Primaquine Motifs, as Potential Cytostatic and Antiplasmodial Agents.

  • Authors : Beus M; Faculty of Pharmacy and Biochemistry University of Zagreb A. Kovačića 1 10 000 Zagreb Croatia.; Rajić Z

  • Source: ChemistryOpen [ChemistryOpen] 2018 Aug 21; Vol. 7 (8), pp. 624-638. Date of Electronic Publication: 2018 Aug 21 (Print Publication: 2018).Publisher: Wiley-VCH Verlag Country of Publication: Germany NLM ID: 101594811 Publication Model: eCollection Cited Medium: Print ISSN: 2191-1363

Record details

×
  • 1-10 of  49 results for ""Olgen S""